ResMed Inc. vs Stanley Black & Decker, Inc. — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.73B), while Stanley Black & Decker, Inc. trades at $91.6 (market cap $13.85B). The key difference: ResMed Inc. is far larger — about 2.3× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.66%). Which is the better fit depends on your goals.
| RMD | SWK | |
|---|---|---|
Market Cap | $31.73B | $13.85B |
Sector | Health | — |
52-Week High | $283.28 | $104.00 |
52-Week Low | $182.82 | $62.12 |
Enterprise Value | $31.08B | $18.01B |
Dividend Yield | 1.2% | 3.66% |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
Stanley Black & Decker (SWK) trades at $93.81, down 3.65% on the day, with a bearish technical signal from moving averages and oscillators. The company reported three consecutive quarterly earnings beats, with Q3 2026 results pending. Recent portfolio refinement includes the sale of Excel Industries to Bad Boy Mowers. Valuation metrics show a P/E of 22.94 and P/S of 0.93, with a net income margin of 4.07% for 2025.
The outlook is mixed: analyst consensus is a $98.50 price target with 43% buy ratings, but technical indicators suggest near-term pressure. Opportunities include cost transformation benefits and dividend stability, while risks involve debt levels and industrial demand volatility. The stock's current price is near the low end of analyst targets, indicating potential upside if fundamentals strengthen.
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →